Recombinant antigens
EBNA1
for Epstein-barr virus (EBV)
EBNA1 has a predominant role in the maintenance of latent EBV infections and is expressed in all EBV infections and all EBV-associated malignant tissues. It contains a Gly-Ala repeated domain flanked by two unique regions. The central , C-terminus and N-terminus regions have been described as potentially antigenic.
- NAME
- Ebna1
- DESCRIPTION
- Late nuclear antigen
- GEN
- BKRF1
- PURITY
- >95% by observation on SDS-PAGE electrophoresis
- Formats
Liquid solution or dry powder (lyophilised) in vials of 0.1 mg*, 1 mg and bulk.
*under availability, for liquid format
* Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. In addition, we follow a rigorous quality control for each lot.
References of Recombinant antigen EBNA1
Folletos
- Rekom Biotech catalogue
- Recombinant proteins for in vitro diagnosis of human infectious diseases
- Rekom Biotech Top products (Satisfaction guarantee)
- Sexually transmitted diseases (STD)
- Recombinant antigens for diagnosis of EBV
Videos
- How to reconsitute lyophizated vials
- Recombinant antigens for the diagnosis of Epstein-Barr Virus (EBV)
Evaluaciones
Related proteins
Reagent sheet
- NAME
- EBNA1
- DESCRIPTION
- Late nuclear antigen
- PURITY
- >95% by observation on SDS-PAGE electrophoresis
- Formats
Liquid solution or dry powder (lyophilised) in vials of 0.1 mg*, 1 mg and bulk.
*under availability, for liquid format
* Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. In addition, we follow a rigorous quality control for each lot.
